WNK2 and melanoma: In addition, the RAS/BRAF/MEK/ERK mitogen-activated protein kinase pathway is constitutively activated in melanoma via an activating mutation in BRAF or autocrine growth factor stimulation [71] and is a crucial modulator of melanoma initiation and progression [72].